Immunotherapy reassessed.
作者信息
Williams C J
出版信息
Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):920-1. doi: 10.1136/bmj.284.6320.920-a.
Abstract
摘要
相似文献
1
Immunotherapy reassessed.免疫疗法重新评估。
Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):920-1. doi: 10.1136/bmj.284.6320.920-a.
2
[Use of monoclonal antibodies in the immunotherapy of neoplasms].[单克隆抗体在肿瘤免疫治疗中的应用]
Przegl Lek. 1989;46(4):420-6.
3
Letter: Immunotherapy inaccuracy.信函：免疫疗法的不准确性。
Med J Aust. 1975 Dec 6;2(23):887.
4
Report on the Keystone symposium: cellular immunity and the immunotherapy of cancer II.关于基石研讨会的报告：细胞免疫与癌症免疫疗法II。
J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):79-87.
5
[Interleukin-2 and cancer immunotherapy].[白细胞介素-2与癌症免疫疗法]
Vopr Onkol. 1989;35(2):141-50.
6
Immunotherapy of cancer in animals: models or muddles?动物癌症免疫疗法：模型还是困境？
J Natl Cancer Inst. 1976 Feb;56(2):207-10. doi: 10.1093/jnci/56.2.207.
7
[Mechanisms of the antineoplastic action of viruses and the problem of the immunotherapy of tumors].[病毒的抗肿瘤作用机制与肿瘤免疫治疗问题]
Vopr Onkol. 1988;34(11):1291-300.
8
[A new approach to immunotherapy of cancer based on autologous T-lymphocytes].[一种基于自体T淋巴细胞的癌症免疫治疗新方法]
Medicina (B Aires). 1987;47(3):307-12.
9
Use of activated natural killer cells for tumor immunotherapy in mouse and human.活化自然杀伤细胞在小鼠和人类肿瘤免疫治疗中的应用。
Methods Mol Biol. 2000;121:81-94. doi: 10.1385/1-59259-044-6:81.
10
[Immunotherapy of malignant diseases].[恶性疾病的免疫治疗]
Bull Cancer. 1995;82 Suppl 2:127s-138s.
引用本文的文献
1
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.转移性乳腺癌联合化疗（VAC/FMC）与免疫刺激：一项比较短小棒状杆菌不同给药时间和途径的随机研究。
Klin Wochenschr. 1984 Feb 15;62(4):162-7. doi: 10.1007/BF01731638.
本文引用的文献
1
2
The immunology of transplantation.移植免疫学
Harvey Lect. 1956(Series 52):144-76.
3
Immunity to methylcholanthrene-induced sarcomas.对甲基胆蒽诱导肉瘤的免疫性。
J Natl Cancer Inst. 1957 Jun;18(6):769-78.
4
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.甲基胆蒽诱发的原种系小鼠肿瘤的抗原特性。
Cancer Res. 1953 Dec;13(12):835-7.
5
Immunotherapy of cancer: current status.癌症免疫疗法：现状
Prog Exp Tumor Res. 1980;25:61-88. doi: 10.1159/000403177.
6
Immunology in tumor therapeutics: an overview.肿瘤治疗中的免疫学：概述
Del Med J. 1980 Apr;52(4):197-209.
7
Specific antigens of tumors and leukemias of experimental animals.实验动物肿瘤和白血病的特异性抗原
Med Clin North Am. 1966 May;50(3):901-12. doi: 10.1016/s0025-7125(16)33187-x.
8
Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.体外淋巴细胞介导的细胞毒性。体液抗体的诱导和抑制作用以及效应细胞的性质。
Transplant Rev. 1972;13:91-114. doi: 10.1111/j.1600-065x.1972.tb00061.x.
9
BCG and cancer.卡介苗与癌症
N Engl J Med. 1974 Jun 27;290(26):1458-69. doi: 10.1056/NEJM197406272902605.
10
BCG and cancer (first of two parts).卡介苗与癌症（两部分中的第一部分）
N Engl J Med. 1974 Jun 20;290(25):1413-20. doi: 10.1056/NEJM197406202902506.
Zotero 插件